Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03642626
Title MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

childhood B-cell acute lymphoblastic leukemia

B-cell adult acute lymphocytic leukemia

relapsed/refractory diffuse large B-cell lymphoma

Therapies

Cyclophosphamide + Fludarabine + Tisagenlecleucel

axicabtagene ciloleucel + Cyclophosphamide + Fludarabine

Age Groups: adult | senior | child
Covered Countries USA

Facility Status City State Zip Country Details
Masonic Cancer Center at University of Minnesota Recruiting Minneapolis Minnesota 55455 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field